Clinigen Group plc (‘Clinigen’ or the ‘Group’) (LSE: CLIN) (AIM: CLIN)
the specialty global pharmaceutical company today announces the
acquisition of the global rights to the oncology support therapy, Ethyol ®
(amifostine) from AstraZeneca.
for Clinigen Group Further Strengthens Oncology Support Portfolio with Acquisition of Ethyol® (amifostine), from AstraZeneca investment picks